Suchergebnisse - (Subject:"PARP inhibitor")

PubPharm (2.848)

31

Does the choice of platinum doublet matter? A study to evaluate the impact of platinum doublet choice for treatment of platinum-sensitive ovarian cancer recurrence on the development of future PARP inhibitor and platinum resistance

enthalten in: Gynecologic oncology | 2024

von Levine, M. | Wang, H. | Sriram, B. | +11

32

PARP inhibitor plus radiotherapy reshape the immune suppressive microenvironment and potentiate the efficacy of immune checkpoint inhibitors in tumors with IDH1 mutation

enthalten in: Cancer letters | 2024

von Hu, X. | Zhao, M. | Bai, M. | +5

33

Natural pentacyclic triterpenoid from Pristimerin sensitizes p53-deficient tumor to PARP inhibitor by ubiquitination of Chk1

enthalten in: Pharmacological research | 2024

von Tao, L. | Xia, X. | Kong, S. | +3

34

A case of hereditary breast and ovarian cancer syndrome of initially presented as cancer of unknown primary with lymph node metastases unveiled by genetic analysis

enthalten in: International cancer conference journal | 2024

von Yamada, J. | Fukuda, K. | Sugawara, T. | +8

35

Metabolism-focused CRISPR screen unveils mitochondrial pyruvate carrier 1 as a critical driver for PARP inhibitor resistance in lung cancer

enthalten in: Molecular carcinogenesis | 2024

von Furusawa, T. | Cavero, R. | Liu, Y. | +11

36

Prior authorization for FDA-approved PARP inhibitors in ovarian cancer

enthalten in: Gynecologic oncology reports | 2024

von Smith, A. | Apple, A. | Hugo, A. | +2

37

PARP inhibitors in ovarian cancer

enthalten in: Seminars in oncology | 2024

von Goldlust, I. | Guidice, E. | Lee, J.

38

Recent advances and future strategies in first-line treatment of ES-SCLC

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Gomez-Randulfe, I. | Leporati, R. | Gupta, B. | +2

39

Cardioprotective Effects of PARP Inhibitors : A Re-Analysis of a Meta-Analysis and a Real-Word Data Analysis Using the FAERS Database

enthalten in: Journal of clinical medicine | 2024

von Han, J. | Seo, Y. | Kwon, J. | +2

40

Targeting EMSY-mediated methionine metabolism is a potential therapeutic strategy for triple-negative breast cancer

enthalten in: Cell reports. Medicine | 2024

von Liu, C. | Chen, L. | Cai, Y. | +5